References
- Meldrum DR, Dinarello CA, Shames BD, Cleveland JC, Cain BS, Benerjee A, et al. Ischemic preconditioning decreases postischemic myocardial tumor necrosis factor alpha production. Circulation. 1998; 98: 214–9
- Hiasa G, Hamada M, Ikeda S, Hiwada K. Ischemic preconditioning and lipopolysaccharide attenuate nuclear factor kappa B activation and gene expression of inflammatory cytokine in the ischemia-reperfused rat heart. Jpn Circ J. 2001; 65: 984–90
- Tsuchida A, Miura T, Miki T, Shimamoto K, Iimura O. Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning. Cardiovasc Res. 1992; 26: 456–61
- Miki T, Cohen MV, Downey JM. Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits. Mol Cell Biochem. 1998; 186: 3–12
- Schultz JE, Hsu A, Gross GJ. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide- sensitive mechanism in the rat heart. Cardiovasc Res. 1996; 78: 1100–4
- Goto M, Liu Y, Yang X, Ardell J, Cohen M, Downey J. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res. 1995; 77: 611–21
- Vegh A, Szekeres L, Parratt J. Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmias in anaesthetized dogs. Br J Pharmacol. 1991; 104: 294–5
- Yang X, Liu Y, Scicli G, Webb C, Carretero O. Role of kinins in the cardioprotective effect of preconditioning: study of myocardial ischemia/reperfusion injury. Hypertension. 1997; 34: 24–30
- Brew EC, Mitchell MB, Rehring TF, Gamboni-Robertson F, McIntyre RC, Jr, Harken AH, et al. Role of bradykinin in cardiac functional protection after global ischemia-reperfusion in rat heart. Am J Physiol. 1995; 269: H1370–H1378
- Hennein H, Ebba H, Rodriguez J, Merrick S, Keith F, Bronstern M, et al. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg. 1994; 108: 626–35
- Taggart P, El-Fiky M, Carter R, Bowman A, Wheatley D: Respiratory dysfunction after uncomplicated cardiopulmonary bypass. Ann Thorac Surg. 1993;56:1123–8.
- Partrick D, Moore F, Moore E, Biffl W, Sauaia A, Barnett CJ. The proinflamatory profile of interleukin-6, interleukin-8 and soluble intercellular adhesion molecule-1 in postinjury multiple organ failure. Am J Surg. 1996; 112: 1301–6
- Shigematsu S, Ishida S, Gute D, Korthuis R. Postischemic anti-inflammatory effects of bradykinin preconditioning. Am J Physiol Heart Circ Physiol. 2001; 280: 441–54
- Belhomme D, Peynet J, Louzy M, Launay JM, Kitakaze M, Menasche P. Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation 1999; 100: II340–344
- Wan S, LeClerc J-L, Vincent J-L. Cytokines responses to cardiopulmonary bypass: Lessons learned from cardiac transplantation. Ann Thorac Surg. 1997; 63: 269–76
- Lotz M. Interleukin-6. Cancer Invest. 1993; 11: 732–42
- Kinugawa K, Takahashi T, Kohmoto O, Yao A, Aoyagi T, Momomura S, et al. Nitric oxide-mediated effects of interleukin-6 on [Ca2 + ]i and cell concentration in cultured chick ventricular myocytes. Cardiovasc Res. 1994; 75: 285–95
- Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 1992; 257: 387–9
- Kukielka GL, Smith CW, LaRosa GJ, Manning AM, Mendoza LH, Daly TJ, et al. Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. J Clin Invest. 1995; 95: 89–103
- Kawamura T, Wakusawa R, Okada K, Inada S. Elevation of cytokines during open heart surgery with cardiopulmonary bypass: Participation of interleukin 8 and 6 in reperfusion injury. Can J Anaesth. 1993; 40: 1016–21
- Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res. 2002; 53: 31–47
- Taniguchi T, Koido Y, Aiboshi J, Yamashita T, Suzaki S, Kurokawa A. Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Crit Care Med. 1999; 27: 1262–4
- Azab SRE, Rosseel PMJ, Lange JJD, Groeneveld ABJ, Strik RV, Wijk EMV, et al. Dexamethasone decreases the pro- to anti-inflammatory cytokine ratio during cardiac surgery. Br J Anaesth. 2002; 88: 496–501
- Loisa P, Rinne T, Laine S, Hurme M, Kaukinen S. Anti-inflammatory cytokine response and the development of multiple organ failure in severe sepsis. Acta Anaeth Scand. 2003; 47: 319–25
- Wang X, Trottier G, Loutzenhiser R. Determinants of renal afferent arteriolar actions of bradykinin: Evidence that multiple pathways mediate responses attributed to EDHF. Am J Physiol Renal Physiol. 2003; 285: F540–F549
- Mombouli J, Nakashima M, Hamra M, Vanhoutte P. Endothelium-dependent relaxation and hyperpolarization evoked by bradykinin in canine coronary arteries: Enhancement by exercise-training. Br J Pharmacol. 1996; 117: 413–8
- Marcondes S, Antunes E. The plasma and tissue kininogen-kallikrein-kinin system: Role in the cardiovascular system. Curr Med Chem Cardiovasc Hematol Agents. 2005; 3: 33–44
- Matoba S, Tatsumi T, Keira N, Kawahara A, Akashi K, Kobara M, et al. Cardioprotective effect of angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes. Circulation. 1999; 99: 817–22
- Feng J, Li H, Rosenkranz E. Bradykinin protects the rabbit heart after cardioplegic ischemia via NO-dependent pathways. Ann Thorac Surg. 2000; 70: 2119–24
- Feng J, Rosenkranz E. Bradykinin pretreatment improves ischemia tolerance of the rabbit heart by tyrosine kinase mediated pathways. Ann Thorac Surg. 1999; 68: 1567–72
- Feng J, Rosenkranz E. Bradykinin pretreatment improves ischemia rabbit heart: Role of potassium channels. J Am Coll Cardiol. 1999; 33: 357A
- Morgan E, Boyle EJ, Yun W, Griscavage-Ennis J, Farr A, Canty TJ, et al. An essential role for NFkB in the cardioadaptive response to ischemia. Ann Thorac Surg. 1999; 68: 377–82
- Carter D. Modulation of cellular AP-1 DNA binding activity by heat shock proteins. FEBS Lett. 1997; 416: 81–5
- Vayssier M, Favatier F, Pinot F, Bachelet M, Polla B. Tobacco smoke induces coordinate activation of HSF and inhibition of NFkB in human monocyte: Effect on TNFalpha release. Biochem Biophys Res Commun. 1998; 252: 249–56
- Massoudy P, Zahler S, Becker B, Braun S, Barankey A, Meisner H. Evidence for inflammatory responses of the lungs during coronary artery bypass grafting with cardiopulmonary bypass. Chest. 2001; 119: 31–6
- Jaeschke H. Mechanism of reperfusion injury after warm ischemia of the liver. J Hepatol. 1998; 21: 402–8
- Tamion F, Richard V, Lacoume Y, Thuillez C. Intestinal preconditioning prevents systemic inflammatory response in hemorrhagic shock. Role of HO-1. Am J Physiol Gastrointest Liver Physiol. 2002; 283: 408–14
- Brix-Christensen V, Vestergaard C, Chew M, Johnsen CK, Anderson SK, Dreyer K, et al. Plasma cytokines do not reflect expression of pro- and anti-inflammatory cytokine mRNA at organ level after cardiopumonary bypass in neonatal pigs. Acta Anaethesiol Scand. 2003; 47: 525–31